Bioceres Crop Solutions (BIOX) Stock Forecast & Price Target

$7.55

+0.17 (+2.30%)

(As of 10/18/2024 ET)

Bioceres Crop Solutions - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 6 Analyst Ratings

Sell
0

Hold
0

Buy
6

Based on 6 Wall Street analysts who have issued ratings for Bioceres Crop Solutions in the last 12 months, the stock has a consensus rating of "Buy." Out of the 6 analysts, 4 have given a buy rating, and 2 have given a strong buy rating for BIOX.

Consensus Price Target

$13.00
72.19% Upside

According to the 6 analysts' twelve-month price targets for Bioceres Crop Solutions, the average price target is $13.00. The highest price target for BIOX is $16.00, while the lowest price target for BIOX is $10.00. The average price target represents a forecasted upside of 72.19% from the current price of $7.55.

BIOX Analyst Ratings Over Time

Type	Current Forecast 10/21/23 to 10/20/24	1 Month Ago 9/21/23 to 9/20/24	3 Months Ago 7/23/23 to 7/22/24	1 Year Ago 10/21/22 to 10/21/23
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	2 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$13.00	$13.63	$19.00	$23.67
Forecasted Upside	72.19% Upside	65.35% Upside	70.10% Upside	123.27% Upside
Consensus Rating	Buy	Buy	Buy	Buy

2024's Must-Watch Stocks! (Ad)

Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

[Unlock Your Report Now]

BIOX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BIOX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Bioceres Crop Solutions Stock vs. The Competition

Type	Bioceres Crop Solutions	Consumer Staples Companies	S&P 500
Consensus Rating Score	3.33	2.43	2.50
Consensus Rating	Buy	Hold	Hold
Predicted Upside	72.19% Upside	131.66% Upside	6.18% Upside
News Sentiment Rating	Neutral News See Recent BIOX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/17/2024	Canaccord Genuity Group 1 of 5 stars		Lower Target	Buy ➝ Buy	$12.50 ➝ $10.00	+37.74%
9/11/2024	Roth Mkm 1 of 5 stars		Lower Target	Buy ➝ Buy	$15.00 ➝ $13.00	+55.88%
9/11/2024	Oppenheimer 3 of 5 stars		Lower Target	Outperform ➝ Outperform	$17.00 ➝ $16.00	+84.97%
9/11/2024	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$25.00 ➝ $13.00	+50.29%
7/2/2024	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Fortune Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 09:28 PM ET.

BIOX Forecast - Frequently Asked Questions

: According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Bioceres Crop Solutions is $13.00, with a high forecast of $16.00 and a low forecast of $10.00.
: 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bioceres Crop Solutions in the last twelve months. There are currently 4 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BIOX shares.
: According to analysts, Bioceres Crop Solutions's stock has a predicted upside of 72.19% based on their 12-month stock forecasts.
: Bioceres Crop Solutions has been rated by research analysts at Canaccord Genuity Group, Lake Street Capital, Oppenheimer, and Roth Mkm in the past 90 days.
: Analysts like Bioceres Crop Solutions more than other "consumer staples" companies. The consensus rating for Bioceres Crop Solutions is Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how BIOX compares to other companies.